<!DOCTYPE html>
<!--[if lt IE 7]>      <html class="no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]-->
<!--[if IE 7]>         <html class="no-js lt-ie9 lt-ie8"> <![endif]-->
<!--[if IE 8]>         <html class="no-js lt-ie9"> <![endif]-->
<!--[if gt IE 8]><!--><html class="no-js"> <!--<![endif]-->
    <head>
        <meta charset='utf-8'>
        <meta http-equiv='X-UA-Compatible' content='IE=edge,chrome=1'>
        <title>DC Code - § 48-902.14. Treatment of controlled substance analogues.</title>
        <meta name='description' content='A simple, free browser for the Washington, DC Code'>
        <meta name='viewport' content='width=device-width'>
        <link href='http://fonts.googleapis.com/css?family=Open+Sans:400italic,700italic,400,700' rel='stylesheet' type='text/css'>
        <link rel='stylesheet' type='text/css' href='/simple/css/reset.css' media='screen' />
        <link rel='stylesheet' type='text/css' href='/simple/css/site.css' media='screen' />
        <link rel='stylesheet' type='text/css' href='/simple/css/body.css' media='screen' />
        <link rel='stylesheet' type='text/css' href='/simple/css/print.css' media='print' />
        <link rel='stylesheet' type='text/css' href='/simple/css/icons/style.css' media='screen' />
    </head>
    <body>
        <div class="container">
            <header>
                <div class='right'>
                    <form id='search-form'>
                        <input id='search-box' type='text' placeholder="15-101"
                        /><button id='search-button'><span class="icon-search"></span></button>
                    </form>
                </div>
                <p id='sitename'>Code of the District of Columbia (Unofficial)</p>
            </header>

            <div class="clearfix" style="width: 100%;">

            <div id='sidebar' class='col4'>
                
                    <h2>You Are Here</h2>
                    <ul class="ancestors">
                    
                        <li><a href="/simple">Code of the District of Columbia</a></li>
                    
                        <li>↪ <a href="/simple/Title-48">Title 48. Foods and Drugs</a></li>
                    
                        <li>↪ <a href="/simple/Title-48/Chapter-9">Chapter 9. Controlled Substances</a></li>
                    
                        <li>↪ <a href="/simple/Title-48/Chapter-9/Unit-A">Unit A. Controlled Substances Act</a></li>
                    
                        <li>↪ <a href="/simple/Title-48/Chapter-9/Unit-A/Subchapter-II">Subchapter II. Standards and Schedules</a></li>
                    
                    <li>↪ § 48-902.14. Treatment of controlled substance analogues.</a></li>
                    </ul>
                

                
                    <h2>Previous Section</h2>
                    <p><a href="/simple/sections/48-902.13.html">§ 48-902.13. Revising and republishing of schedules.</a>
                

                
                    <h2>Next Section</h2>
                    <p><a href="/simple/Title-48/Chapter-9/Unit-A/Subchapter-III">Subchapter III. Regulation of Manufacture, Distribution, and Dispensing</a>
                

                <h2>Current as of...</h2>
                <p class="recency">December 13, 2013 and through D.C. Act 20-210 (except D.C. Acts 20-130, 20-157, and 20-204)</p>
            </div>
            <div class='col8'>
                <div id='content'>
                    <h1>§ 48-902.14. Treatment of controlled substance analogues.</h1>


     

    

    

    <div class="primary-content"> 

    
        <p class=" has-level-num " style="padding-left: 0em">
            
                
                    <span class="level-num" style="">(a) </span>
                
                    <span class="" style="">A controlled substances analogue shall, to the extent intended for human consumption, be treated for the purposes of any District of Columbia law as a controlled substance in Schedule I.</span>
                
            
        </p>
    
        <p class=" has-level-num " style="padding-left: 0em">
            
                
                    <span class="level-num" style="">(b) </span>
                
                    <span class="" style="">Except as provided in subsection (c) of this section, the term &quot;controlled analogue&quot; means:</span>
                
            
        </p>
    
        <p class=" has-level-num " style="padding-left: 2.25em">
            
                
                    <span class="level-num" style="">(1) </span>
                
                    <span class="" style="">a substance with a chemical structure that is substantially similar to the chemical structure of a controlled substance in Schedule I or II;</span>
                
            
        </p>
    
        <p class=" has-level-num " style="padding-left: 2.25em">
            
                
                    <span class="level-num" style="">(2) </span>
                
                    <span class="" style="">A substance that has a stimulant, depressant, or hallucinogenic effect on the central nervous system that is substantially similar to or greater than the stimulant, depressant, or hallucinogenic effect on the central system of a controlled substance in Schedule I or II; or</span>
                
            
        </p>
    
        <p class=" has-level-num " style="padding-left: 2.25em">
            
                
                    <span class="level-num" style="">(3) </span>
                
                    <span class="" style="">A substance that, with respect to a particular person, is represented to have or is intended to have a stimulant, depressant, or hallucinogenic effect on the central nervous system that is substantially similar to, or greater than the stimulant, depressant, or hallucinogenic effect on the central nervous system of a controlled substance in Schedule I or II.</span>
                
            
        </p>
    
        <p class=" has-level-num " style="padding-left: 0em">
            
                
                    <span class="level-num" style="">(c) </span>
                
                    <span class="" style="">Such term does not include:</span>
                
            
        </p>
    
        <p class=" has-level-num " style="padding-left: 2.25em">
            
                
                    <span class="level-num" style="">(1) </span>
                
                    <span class="" style="">A controlled substance;</span>
                
            
        </p>
    
        <p class=" has-level-num " style="padding-left: 2.25em">
            
                
                    <span class="level-num" style="">(2) </span>
                
                    <span class="" style="">Any substance for which there is an approved new drug application;</span>
                
            
        </p>
    
        <p class=" has-level-num " style="padding-left: 2.25em">
            
                
                    <span class="level-num" style="">(3) </span>
                
                    <span class="" style="">With respect to a particular person any substance, if an exemption is in effect for investigational use, for that person, under § 505 of the Federal Food, Drug, and Cosmetic Act, approved June 25, 1938 (52 Stat. 1052, 21 U.S.C. § 355) to the extent conduct with respect to such substance is pursuant to such exemption; or</span>
                
            
        </p>
    
        <p class=" has-level-num " style="padding-left: 2.25em">
            
                
                    <span class="level-num" style="">(4) </span>
                
                    <span class="" style="">Any substance to the extent not intended for human consumption before such an exemption takes effect with respect to that substance.</span>
                
            
        </p>
    

    </div>

    <div class="annotations"> 

    
        <p class="subheading " style="padding-left: 2.25em">
            
                
                    <span class="level-heading" style="">History</span>
                
            
        </p>
    
        <p class=" " style="padding-left: 2.25em">
            
                
                    <span class="" style="">(August 4, 1981, <a href='http://openlims.org/public/L4-29.pdf'>D.C. Law 4-29</a>, § 214, as added as added May 9, 2000, <a href='http://openlims.org/public/L13-99.pdf'>D.C. Law 13-99</a>, § 2(b), 47 DCR 791.)</span>
                
            
        </p>
    
        <p class="subheading " style="padding-left: 2.25em">
            
                
                    <span class="level-heading" style="">Legislative History of Law 13-99</span>
                
            
        </p>
    
        <p class=" " style="padding-left: 2.25em">
            
                
                    <span class="" style="">For Law 13-99, see notes following <a href='/simple/sections/48-902.04.html'>§ 48-902.04</a>.</span>
                
            
        </p>
    

    </div>



                </div>
            </div>
            </div>
            <footer>
                <p>This is a fast, unofficial interface to the
                <a href='http://dccouncil.us/UnofficialDCCode'>Unofficial DC Code</a> by
                <a href='https://github.com/openlawdc'>openlawdc</a>.
                Please <a href='https://github.com/openlawdc/simple-generator/issues'>report issues</a>.</p>
            </footer>
        </div>
        <script>
        ROOTDIR = "/simple";
        </script>
        <script src='/simple/js/jquery-1.11.0.min.js'></script>
        <script src='/simple/js/search.js'></script>
    </body>
</html>
